Brief: Chromogenics Q3 EBITDA Loss Widens To SEK 17.4 Million

ChromoGenics AB

22/11/2019 07:37

Nov 22 (Reuters) - ChromoGenics AB  CHRO.ST :
    * INTERIM REPORT JANUARY 1 - SEPTEMBER 30, 2019
    * Q3 NET SALES FOR PERIOD AMOUNTED TO SEK 14.0 (0.0)
    * Q3 EBITDA LOSS SEK 17.4 MILLION VERSUS LOSS SEK 10.8
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr5xXxr6 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))